One-year efficacy of etanercept in ankylosing spondylitis

被引：0
|
作者：
Davis, JC
Van der Heijde, DM
Braun, J
Dougados, M
Cush, JJ
Clegg, DO
Kivitz, AJ
Inman, RD
Solinger, A
Whitmore, J
Tsuji, W
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Hosp Maastricht, Maastricht, Netherlands
[3] Rheumazentrum Ruhrgebiet, Herne, Germany
[4] Hop Cochin, F-75674 Paris, France
[5] Presbyterian Med Ctr, Dallas, TX USA
[6] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA
[7] Altoona Ctr Clin Res, Duncansville, TX USA
[8] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[9] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [41] Multiple sclerosis following etanercept treatment for ankylosing spondylitis
    Pfueller, C. F.
    Seipelt, E.
    Zipp, F.
    Paul, F.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (05) : 397 - U3
  • [42] Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
    Brandt, J
    Listing, J
    Haibel, H
    Sörensen, H
    Schwebig, A
    Rudwaleit, M
    Sieper, J
    Braun, J
    RHEUMATOLOGY, 2005, 44 (03) : 342 - 348
  • [43] Two-year etanercept therapy does not inhibit radiographic progression in patients with ankylosing spondylitis
    van der Heijde, D. M.
    Landewe, R. D. M.
    Ory, R.
    Vosse, D.
    Zhou, L.
    Tsuji, W.
    Davis, J. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 81 - 81
  • [44] One-year follow-up of two exercise interventions for the management of patients with ankylosing spondylitis -: A randomized controlled trial
    Fernández-de-las-Peñas, C
    Alonso-Blanco, C
    Alguacil-Diego, IM
    Miangolarra-Page, JC
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2006, 85 (07) : 559 - 567
  • [45] Long-term efficacy, including halting of radiographicprogression, and safety of etanercept in patients with ankylosing spondylitis
    Dijkmans, B.
    Sridharan, S.
    Fatenejad, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 187 - 187
  • [46] The efficacy of infliximab in ankylosing spondylitis
    Christopher T. Ritchlin
    Current Rheumatology Reports, 2004, 6 (2) : 96 - 96
  • [47] Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
    Braun, J
    Brandt, J
    Listing, J
    Zink, A
    Alten, R
    Burmester, G
    Gromnica-Ihle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 229 - 234
  • [48] Serbian etanercept registry. One-year follow-up
    Vojinovic, J.
    Susic, G.
    Damjanov, N.
    Stojanovic, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 558 - 558
  • [49] Activity of ankylosing spondylitis in women within one year after childbirth
    Krichevskaya, Olga A.
    Dubinina, Tatyana V.
    Ilinykh, Ekaterina V.
    Glukhova, Svetlana I.
    Demina, Anastasia B.
    Andrianova, Irina A.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (05) : 647 - 653
  • [50] One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study
    Chimenti, Maria Sole
    Fonti, Giulia Lavinia
    Conigliaro, Paola
    Sunzini, Flavia
    Scrivo, Rossana
    Navarini, Luca
    Triggianese, Paola
    Peluso, Giusy
    Scolieri, Palma
    Caccavale, Rosalba
    Diamanti, Andrea Picchianti
    De Martino, Erica
    Salemi, Simonetta
    Birra, Domenico
    Altobelli, Alessio
    Paroli, Marino
    Bruzzese, Vincenzo
    Lagana, Bruno
    Gremese, Elisa
    Conti, Fabrizio
    Afeltra, Antonella
    Perricone, Roberto
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (07) : 813 - 821
12345